Company Profile

BioFactura Inc
Profile last edited on: 10/8/2020      CAGE: 339S7      UEI: C1ZWQAYK4J58

Business Identifier: Hiigh-value biosimilars: follow-on biologics or generic biopharmaceuticals
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8435 Progress Drive Suite Z
Frederick, MD 21701
   (301) 315-8002
Location: Single
Congr. District: 06
County: Frederick

Public Profile

BioFactura develops and commercializes high-value biosimilars ie follow-on biologics or generic biopharmaceuticals, biodefense medical countermeasures, and client-selected novel drugs using the firm's patented StableFast Biomanufacturing Platform, a novel system rapidly to generate stable NS0 cell lines for biopharmaceutical manufacturing. Elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patented selection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks. In Septmeber 2019 it was announced that BARDA (Biomedical Advanced Research and Development Authority) had awarded BioFactura Inc a $67.4 Million Advanced Development Contract for its Smallpox Biodefense Therapeutic/

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Alex Deseabra -- President

  Darryl Sampey -- CEO, President & Co-Founder

  Luis M Branco

  Pascal Courville -- Scientist

  Jeffrey N Hausfeld -- Chairman and Chief Medical Officer